Stay Informed on Key Developments

Investor News and Updates

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

371 - 380of 392 News

October 26, 2017

Third quarter of 2017

Bayer: Sales and earnings increased

October 17, 2017

Not intended for U.S. and UK Media

Bayer submits its extended half-life hemophilia A compound for marketing authorization in Japan

October 13, 2017

Milestone on Bayer’s path to completing the planned acquisition of Monsanto:

Bayer signs agreement to sell selected Crop Science businesses to BASF for EUR 5.9 billion

October 05, 2017

Not intended for U.S. and UK Media

Bayer’s NAVIGATE ESUS study halted early as it indicated comparable efficacy between treatment arms

September 29, 2017

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer cedes control of Covestro

September 19, 2017

Future of Farming Dialog 2017:

Crop Science Division of Bayer well positioned to fulfill future customer, market and societal needs

September 15, 2017

Not intended for U.S. and UK Media

Bayer receives positive CHMP opinion for rivaroxaban 10 mg once daily for the extended prevention of venous thromboembolism

September 14, 2017

Not intended for U.S. and UK Media

Bayer receives FDA approval for Copanlisib in adults with relapsed follicular lymphoma after two prior systemic therapies

September 13, 2017

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer places 9.4 percent stake in Covestro

September 12, 2017

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer further reduces holding in Covestro

Inform Yourself on Special Topics

Investor News and Updates

Control Weeds, Not Farming

Everything You Need to Know About Glyphosate

Managing Glyphosate Litigation

Managing and Mitigating PCB Litigation Risk